Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan.
1995 • 320 citations
Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels.
1987 • 251 citations
Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization
1995 • 121 citations
[18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
1995 • 115 citations
The role of technetium-99m sestamibi whole-body scans in diagnosing metastatic Hurthle cell carcinoma of the thyroid gland after total thyroidectomy: a comparison with iodine-131 and thallium-201 whole-body scans
1994 • 90 citations
Thallium-201 imaging in the follow-up of differentiated thyroid carcinoma.
1988 • 62 citations
The role of iodine-131 and thallium-201 imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma
1993 • 59 citations
Technetium-99m-tetrofosmin uptake in malignant lung tumours
1995 • 51 citations
Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer.
1995 • 30 citations
Positive thyroid cancer scintigraphy using 99Tcm-tetrofosmin (Myoview)
1995 • 25 citations
Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
1996 • 25 citations
[Bone marrow changes in patients with thyroid carcinoma].
1991 • 3 citations
Cited By (0)
No citing papers found in database